Study Design of a Phase 3, Randomized, Open-Label,...

Biology of Blood and Marrow Transplantation 2018 / 03 Vol. 24; Iss. 3

Study Design of a Phase 3, Randomized, Open-Label, Multicenter Study to Evaluate Ruxolitinib Over BAT in Patients with Corticosteroid-Refractory Chronic Graft vs Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation (REACH-3)

Zeiser, Robert, Ram, Ron, Foley, Stephen Ronan, Yeshurun, Moshe, Locatelli, Franco, Artz, Andrew, Gadbaw, Brian, Atienza, Edric, Hollaender, Norbert, Delaite, Patricia, Teshima, Takanori
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
24
Language:
english
Journal:
Biology of Blood and Marrow Transplantation
DOI:
10.1016/j.bbmt.2017.12.176
Date:
March, 2018
File:
PDF, 325 KB
english, 2018
Conversion to is in progress
Conversion to is failed